BlackRock Capital Allocation Term Trust (NYSE:BCAT) Stock Short Interest Rises 84.2%

Key Points

• Short interest surged 84.2% to 2.52 million shares as of September 15, representing 2.4% of BCAT’s outstanding shares and 2.1 days of average trading volume.
• BCAT shares traded at $13.65, near the lower end of their 12-month range of $13.43 to $16.20, while institutional investors and hedge funds owned 36.12% of the stock.
• The fund declared a monthly dividend of $0.2501 per share, equivalent to $3.00 annually and a stated yield of 22.0%.

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 2,523,119 shares, a growth of 84.2% from the August 31st total of 1,369,920 shares. Currently, 2.4% of the shares of the company are short sold. Based on an average daily volume of 1,213,487 shares, the short-interest ratio is presently 2.1 days.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. NewEdge Advisors LLC increased its stake in shares of BlackRock Capital Allocation Term Trust by 4.6% in the 1st quarter. NewEdge Advisors LLC now owns 17,638 shares of the company's stock worth $249,000 after acquiring an additional 779 shares during the last quarter. Quantinno Capital Management LP boosted its position in shares of BlackRock Capital Allocation Term Trust by 3.3% during the 1st quarter. Quantinno Capital Management LP now owns 41,232 shares of the company's stock valued at $583,000 after acquiring an additional 1,324 shares during the last quarter. Walkner Condon Financial Advisors LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 8.6% in the first quarter. Walkner Condon Financial Advisors LLC now owns 17,613 shares of the company's stock valued at $249,000 after purchasing an additional 1,400 shares during the period. TD Capital Management LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 5.6% in the fourth quarter. TD Capital Management LLC now owns 33,812 shares of the company's stock valued at $479,000 after purchasing an additional 1,805 shares during the period. Finally, Baird Financial Group Inc. grew its holdings in shares of BlackRock Capital Allocation Term Trust by 2.0% in the second quarter. Baird Financial Group Inc. now owns 90,490 shares of the company's stock valued at $1,442,000 after purchasing an additional 1,815 shares during the period. 36.12% of the stock is owned by institutional investors and hedge funds.

BlackRock Capital Allocation Term Trust Stock Performance

Shares of BCAT stock traded up $0.09 on Tuesday, hitting $13.65. The company had a trading volume of 1,068,459 shares, compared to its average volume of 770,511. The company has a 50-day moving average price of $15.43 and a 200-day moving average price of $15.33. BlackRock Capital Allocation Term Trust has a twelve month low of $13.43 and a twelve month high of $16.20.

BlackRock Capital Allocation Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be given a dividend of $0.2501 per share. This represents a $3.00 annualized dividend and a yield of 22.0%. The ex-dividend date is Friday, December 11th.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust NYSE: BCAT is a diversified, closed-end management investment company advised by BlackRock Advisors, LLC. The fund seeks to provide total return through a combination of current income and capital appreciation.

BCAT invests across both equity and debt markets. Its portfolio may include common stocks, preferred securities, convertible securities, investment-grade and below-investment-grade corporate bonds, loans, and other fixed-income instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.